跳至主要内容
临床试验/NL-OMON49603
NL-OMON49603已完成不适用

Cerebral Haemorrhage associated Inflammation: a PET/MRI Study - CHIPS

Radboud Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 years;
  • 2. Supratentorial non-traumatic ICH confirmed by CT, without a confirmed
  • causative lesion on admission CT-angiography (e.g. aneurysm, AVM, DAVF,
  • cerebral venous sinus thrombosis) or other known underlying lesion (e.g.
  • tumour, cavernoma);
  • 3. Minimal haemorrhage volume of 10mL;
  • 4. Inclusion within 24 hours after symptom onset;
  • 5. Patient*s or legal representative*s informed consent.

排除标准

  • 1. Severe infection at admission, requiring antibiotic treatment;
  • 2. Use of immunosuppressive or immune-modulating therapy at admission;
  • 3. Pre-stroke modified Rankin Scale score >= 3;
  • 4. Severe ICH, unlikely to survive the first 72 hours (defined as Glasgow Coma
  • Scale score < 6 at time of consent);
  • 5. Pregnancy or breast-feeding;
  • 6. Standard contraindications to MRI;
  • 7. Administration of a radionuclide within 10 physical half-lives prior to
  • study enrolment;
  • 8. Known prior allergic reaction to gadolinium contrast or one of the
  • constituents of its solution for administration;
  • 9. Severe renal impairment (eGFR <30ml/min/1.73m);
  • 10. Planned neurosurgical haematoma evacuation

研究者

相似试验

Cerebral Haemorrhage associated Inflammation: a... | 临床试验